In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination

Driven by the accelerated advancement of the policy of separation of medicines, as well as aging and consumption upgrades, the market scale of China's medicine circulation industry has grown rapidly
.
At the same time, under the high pressure of policies such as the two-invoice system and centralized procurement, many small and medium-sized pharmaceutical companies were eliminated
.
After experiencing the "throttles", the leading companies in the industry have further consolidated their market positions by relying on their scale advantages, and the industry concentration has been increased
.
Recently, another high-level policy has sent a big signal: the concentration of the pharmaceutical circulation industry will continue to increase in the future
.
On October 28, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-Quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" period", which clearly stated the requirements for increasing industry concentration
.
The "Opinions" propose that by 2025, the pharmaceutical distribution industry will cultivate 1-3 large-scale digital and comprehensive pharmaceutical distribution companies with over 500 billion yuan, 5-10 over 100 billion yuan, and 5-10 over 50 billion yuan.
Yuan specialized and diversified pharmaceutical retail chain enterprises, and about 100 intelligent, characteristic and platform-based pharmaceutical supply chain service enterprises
.
At the same time, the annual sales of the top 100 pharmaceutical wholesale companies accounted for more than 98% of the total pharmaceutical wholesale market; the annual sales of the top 100 pharmaceutical retail companies accounted for more than 65% of the total pharmaceutical retail market; the drug retail chain rate was close to 70%
.
Judging from the above target data, the concentration of the pharmaceutical distribution industry will further increase, and a number of powerful giant companies will be born
.
More than that, the "Opinions" also support cross-regional and cross-ownership mergers and reorganizations of drug distribution companies, and foster large-scale modern drug distribution backbone enterprises
.
Encourage the reorganization of small and medium-sized enterprises and backbone enterprises with network advantages to realize complementary advantages and service extension
.
This also means that a number of small and medium-sized drug companies will be merged or eliminated in the next four years, and industry giants will be the strongest
.
Judging from the current situation of the pharmaceutical circulation industry, the Ministry of Commerce recently released the "Statistical Analysis Report on the Operation of the Pharmaceutical Circulation Industry in 2020".
As of the end of 2020, there were 13,100 pharmaceutical wholesale companies nationwide; there were 6,298 pharmaceutical retail chain companies and stores under their jurisdiction.
312,900 retail pharmacies, 241, 000 retail pharmacies, and 553,900 retail pharmacies
.
The report shows that in 2020, the top 100 pharmaceutical wholesale companies’ main business income accounted for 73.
7% of the total national pharmaceutical market in the same period, an increase of 0.
4% year-on-year
.
The guidance requires that by 2025, the proportion of the top 100 pharmaceutical wholesale companies in the total pharmaceutical market will be further increased by 24.
3% to over 98%
.
This also means that in the next four years, the remaining 13,000 small and medium-sized pharmaceutical wholesale companies will face the situation of integration or elimination
.
So, what should the small and medium-sized drug dealers do in the future? Some analysts believe that those who gain channels have the world
.
Channel merchants may wish to try to shift from a sales type to a service type
.
On the one hand, forming a channel business alliance, through the group, "everyone gathers firewood and the flames are high"; on the other hand, the professional matters are handed over to professional people
.
For example, if you want to ensure the safety and traceability of each link from the factory to the patient's use, you can find a professional supply chain company to cooperate
.
Some people in the industry also pointed out that in the cracks of the country's increased industry concentration, small and medium-sized enterprises that are struggling to survive should actively seek a path of transformation and development
.
It believes that, facing a major reshuffle of the industry, small and medium-sized enterprises that have channel advantages, variety advantages, personnel advantages, and development potential advantages in the region have development potential
.
Under the trend of capital mergers and acquisitions and integration, small and medium-sized enterprises should participate in the integration process as soon as possible to find development possibilities and develop through integration and mergers.

.
window.
_bd_share_config={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"32"},"share":{},"image":{"viewList":["weixin","sqq","qzone","tsina","tqq"," tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:", "viewSize":"24"},"selectShare":{"bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu", "tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}};with(document)0[(getElementsByTagName('head ')[0]||body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js ?cdnversion='+~(-new Date()/36e5)]; Keywords: In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination, medicine Next: Development of energy storage biomedicine industry, Yantai plan 2023 Main business revenue exceeded 200 billion yuan Previous: Shandong: 115 drugs have been transferred out of medical insurance today! [News Search] [Add to Favorites] [Tell a friend] [Print this article] [Close window] There are 0 similar information [View all] Related comments js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; Keywords: In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination, medicine Next: Energy storage biology With the development of the pharmaceutical industry, Yantai plans to surpass 200 billion yuan in revenue from its main business in 2023.
[News Search] [Add to Favorites] [Tell a friend] [Print this article] [Close window] There are 0 similar information [View all] Related comments js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; Keywords: In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination, medicine Next: Energy storage biology With the development of the pharmaceutical industry, Yantai plans to surpass 200 billion yuan in revenue from its main business in 2023.
[News Search] [Add to Favorites] [Tell a friend] [Print this article] [Close window] There are 0 similar information [View all] Related comments